Table 1.
Clinical characteristics of T1DM patients according to the outcome (death/recovery) (n = 11,058).
| Factor | Recovery | Death | p-value | |||
|---|---|---|---|---|---|---|
| N | Descriptive statistics | N | Descriptive statistics | |||
| Sex | Men, % | 5,103 | 50.22% | 500 | 55.80% | 0.0012 |
| Women, % | 5,059 | 49.78% | 396 | 44.20% | ||
| Diabetes duration, years, median [Q1; Q3] | 10,078 | 14 [7; 23] | 896 | 21 [13; 31] | <0.0011 | |
| Age, years, median [Q1; Q3] | 10,162 | 40 [31; 52] | 896 | 55 [41; 65] | <0.0011 | |
| HbA1c, %, median [Q1; Q3] | 6,195 | 7.7 [6.9; 8.8] | 229 | 7.8 [7.0; 8.8] | 0.2771 | |
| BMI, kg/m2, median [Q1; Q3] | 7,648 | 24.75 [21.89; 28.09] | 341 | 25.69 [22.68; 30.25] | <0.0011 | |
| DBP, mmHg, median [Q1; Q3] | 6,379 | 80 [70; 80] | 301 | 80 [78; 80] | <0.0011 | |
| SBP, mmHg, median [Q1; Q3] | 6,389 | 120 [120; 130] | 302 | 130 [120; 135] | <0.0011 | |
| eGFR, ml/min/1.73 m2, median [Q1; Q3] | 5,905 | 92 [74; 109] | 244 | 73 [43; 95] | <0.0011 | |
| Total cholesterol, mmol/l, median [Q1; Q3] | 5,456 | 4.7 [4.1; 5.5] | 213 | 4.7 [4.0; 5.5] | 0.1381 | |
| LDL, mmol/l, median [Q1; Q3] | 2,232 | 2.6 [2.1; 3.4] | 75 | 2.7 [2.0; 3.4] | 0.8391 | |
| HDL, mmol/l, median [Q1; Q3] | 1,869 | 1.4 [1.2; 1.8] | 61 | 1.2 [1.1; 1.5] | 0.0131 | |
| TG, mmol/l, median [Q1; Q3] | 2,691 | 1.1 [0.8; 1.6] | 85 | 1.3 [1.1; 2.0] | <0.0011 | |
| ASCVD, % | 2,913 | 28.67% | 361 | 40.29% | <0.0012 | |
| CKD, % | 4,316 | 42.47% | 502 | 56.03% | <0.0012 | |
| Anti-COVID-19 | 746 | 40.13% | 4 | 4.71% | <0.0013 | |
| Vaccination, % | ||||||
| Anti-COVID-19 | Sputnik V (Gam-COVID-Vac), % | 581 | 5.72% | 2 | 0.22% | – |
| Vaccine | CoviVac, % | 19 | 0.19% | 0 | 0.00% | |
| Sputnik Light, % | 54 | 0.53% | 0 | 0.00% | ||
| EpiVacCorona, % | 32 | 0.31% | 0 | 0.00% | ||
1U-test.
2χ2.
3χ2 with Yates’s correction.
P0 = 0.05/16 = 0.003.
Data are % or median and first, third quartiles [Q1; Q3].
HbA1c, glycated hemoglobin level; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; ASCVD, atherosclerotic cardiovascular disease; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; COVID19, coronavirus disease.